Subscribe to Newsletter

A New Vision for Diabetes

Sponsored by Allergan

Diabetes-related eye disease is now one of the leading causes of blindness among working-age adults globally. On November 14, 2019, our forum, A New Vision for Diabetes, sought to bring together both ophthalmologists and diabetologists to discuss the need for an integrated approach to diabetes management.

Chaired by John Marshall, Professor of Ophthalmology at the UCL Institute of Ophthalmology, the panel kicked off with the challenges facing healthcare professionals. The discussion then moved on to issues related to current standard of care and how new trends, such as telemedicine and virtual clinics, can help overcome current challenges.

Find out what the panelists had to say about diabetes-related eye disease by watching the video today. Why should you watch?

-    To find out how to establish an open, honest discourse between ophthalmologists and diabetologists
-    To unravel the current standards of care for patients with diabetic eye disease, and the issues facing HCPs worldwide
-    To understand how to plan for a more integrated, holistic approach to patient and disease management
-    To earn 2 hours’ worth of CPD points


  • John Marshall, Chair

    Professor of Ophthalmology at the Institute of Ophthalmology University College London

  • Ralph Abraham

    Consultant in Diabetes, Endocrinology and Lipid Disorders London Medical

  • Winfried Amoaku

    Clinical Associate Professor in Ophthalmology & Visual Sciences University of Nottingham

  • Shazli Azmi

    Consultant in Diabetes & Endocrinology Manchester University Foundation Trust

  • Dawn Sim

    Director of Telemedicine & Consultant Ophthalmologist in Medical Retina & Cataract Surgery Moorfields Eye Hospital


John Marshall on the latest innovations in the management of diabetic eye disease

John Marshall, Professor of Ophthalmology at UCL, predicts the biggest issues for diabetes management in the coming years, and discusses the latest innovations and trends in detecting, diagnosing and treating diabetic eye disease.

Ralph Abraham, on educating patients with diabetes, and improving their outcomes

Ralph Abraham, Consultant in Diabetes, Endocrinology and Lipid Disorders and founder of the London Diabetes Center, highlights the importance of educating patients on diabetes prevention and discusses how his own work aims to improve patient outcomes. He also tells us what he thinks ophthalmologists need to know about diabetes management.

Winfried Amoaku on the diabetologist’s role in treating diabetic eye disease

Winfried Amoaku, Clinical Associate Professor of Ophthalmology and Visual Sciences at Nottingham University, discusses the biggest issues associated with diabetic eye disease, the role a diabetologist plays in ongoing treatments, and the current best practice for treating DME.

Shazli Azmi on making the future brighter for patients with diabetes

Shazli Azmi, Consultant in Diabetes and Endocrinology at Manchester University Foundation Trust, describes how microvascular changes can affect diabetic eye disease, talks about the biggest barriers to early intervention in diabetes management, and explains how we can make the future brighter for patients.

Dawn Sim on the use of telemedicine and virtual clinics for patients with diabetic eye disease

Dawn Sim, Director of Telemedicine and Consultant Ophthalmologist in Medical Retina and Cataract Surgery at Moorfields Eye Hospital, shares her thoughts on telemedicine, virtual clinics and other key factors that could help make the future better for patients suffering from diabetic eye disease.


Subspecialties Diabetes

Setting Our Sights on Diabetes

| Aleksandra Jones

Three diabetic eye disease gurus discuss prevention, detection, diagnosis, and treatment – and explain why it’s important to consider the future

Subspecialties Retina

Smart, But Not Smart Enough

| Steve Charles

AI image interpretation will not solve the diabetic retinopathy epidemic

Subspecialties Diabetes

Patient Management 2.0

| Phoebe Harkin

Diabetes prevalence is set to grow by 48 percent over the next 25 years – so where does that leave ophthalmologists?

Subspecialties Diabetes

Shifting to a Systemic Approach

| Anat Loewenstein

What does the future hold for the management – and treatment – of diabetic eye disease?

Subspecialties Cornea / Ocular Surface

A Meeting of Minds

| Sponsored by Allergan

The winners of the ICO-Allergan Advanced Research Fellowship… in conversation.

Subspecialties Diabetes

A New Purpose

| Phoebe Harkin

Could an FDA-approved asthma medication offer a therapeutic pathway for diabetic retinopathy?

Sponsored by

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: